Chronic idiopathic constipation may be the result of an autonomic neuropathy. This hypothesis was tested in 23 constipated patients and 17 age matched controls, using the acetylcholine sweat spot test devised to test autonomic integrity in diabetes. Acetylcholine (0.01%) was injected in the dorsum of the foot painted with a mixture of starch and iodine. Active sweat glands appeared on the surface of the skin as small black dots which were photographed and counted, using a grid with 60 subareas. Two measurements were made: the number of dots per unit subarea (sweat spot test score) and the % number of abnormal subareas (with less than six spots). These two parameters were correlated. The median sweat spot test score was 9*53 in patients and 13.92 in controls (p=0.0001), the receiver operating characteristic curve showing that a score of 12 delimited normal and abnormal subjects. Increasing age was correlated with a low score in patients, probably because of prolonged symptoms. Seventy per cent of patients and one control had a borderline or abnormal number of subareas. These results suggest that idiopathic constipation is associated with a degree of autonomic denervation. The sweat spot test is an easy, inexpensive method to test this hypothesis and deserves a place in the clinical assessment of slow transit constipated patients.
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For many patients with severe chronic constipation no cause can be found, hence the condition is labelled as idiopathic. Chronic The acetylcholine sweat spot test was carried out injecting 0 1 ml of a 1% solution of acetylcholine (Miochol -CooperVision Ltd, Southampton, UK) intradermally using a 25 gauge needle in a marked area of the dorsum of the foot which had previously been painted with a 2% alcholic iodine solution and a suspension of maize starch in arachis oil (100 g in 100 ml). The reaction between sweat, iodine, and starch could be seen about four to five minutes later as fine black dots corresponding to functioning sweat glands (Fig 1) . The marked skin area was photographed and the number of dots counted from a projected negative magnified 10 times on a screen using a 20 x 20 cm grid (64 subareas) centred on the injection site.
The number of dots included in each 2-5 x 2.5 cm subarea of the grid were counted, excluding the four central subareas around the site of injection. The dots touching the upper and left side borders of each subarea were counted while those on the lower and right side were ignored. For 21 subjects (16 patients and five controls) the count was made at different times by three independent observers, two of whom were As suggested by Ryder and coworkers7 the occurrence of five (8.3%) or more subareas with less than six dots was chosen as the criterion for abnormality. The mean number of dots/subarea (sweat spot test score) was also recorded for each subject.
STATISTICAL ANALYSIS
The Mann-Whitney U test was used in the comparison of the sweat spot test scores between patients and controls, and Fisher's exact test for the analysis of abnormal subareas. The effect of a confounding factor such as age, and the relationship between the number of abnormal subareas and the sweat spot test score were analysed using the Spearman correlation coefficient (rho) with correction for ties.
The reliability of the method was also investigated by measuring the level of agreement between observers using the K-statistic. The subjects were allotted to three arbitrarily defined categories for both the sweat spot test score (>11, 11-9 5, <9.5) and the percentage number of abnormal subareas (0, 0-0 033, >0 033). This was believed necessary, because random agreement between three observers for only two categories -that is, normal/abnormal -is very likely to occur, making results difficult to evaluate.
The sensitivity, specificity, and efficiency of the sweat spot test were calculated for both the sweat spot test score and the percentage number of abnormal subareas, and receiver operating characteristic curves were drawn for both parameters. 
Results
The median sweat spot test score in patients (9 53, range 1-20 to 13.4) was significantly lower than in controls (median 13.92, range 9.95 to 21.5, p=0 0001, Fig 2) . In controls the distribution of dots on the skin surface appeared to be uniform (Fig 1) whereas patients had a more patchy distribution (Fig 3) .
There was no significant difference in age between the group of 23 patients (median age 42, range The number of abnormal subareas -that is, those subareas containing fewer than six dotswere also analysed for differences between the two groups. Because of blurring of the photographic image caused by focusing difficulties in some subjects, the number of subareas where counting was possible was less than the maximum of 60. In order to compare the number of 1 Detection ofsubclinical autonomic neuropathy in constipated patients using a sweat test When the patients were analysed as a separate group, the correlation between the sweat spot test score and the % number of abnormal subareas was also significant (p=0.0001, rho= -0.91).
In the 21 subjects in whom the number ofsweat glands were counted by three independent observers, the correlation between their observations were assessed. The K value was 0 81 (z=11.83, p<00001) for the agreement on the sweat spot test score and 0.78 (z= 10-65, p<00001) for the agreement on the abnormal subareas.
The receiver operating characteristic curve is illustrated in Figure 5 . The Spearman correlation test showed a significant correlation (p=0.0001, rho=-0 85) between the number of abnormal subareas and the sweat spot test score for all subjects (Fig 4) . The intradermal injection of acetylcholine is effective in stimulating sweat glands because acetylcholine, and not noradrenaline, is the post ganglionic sympathetic neurotransmitter in sudomotor fibres.23 In the presence of exogenous acetylcholine a normal sweat response should therefore be expected even if nerve degeneration precludes adequate transmitter release. Normal response to the test, however, still depends on an intact nerve supply. Acetylcholine is known to be cotransmitted with vasoactive intestinal polypeptide at the synapse between the sympathetic nerve and the sweat gland, vasoactive intestinal polypeptide probably being responsible for the local vasodilation which is necessary for a normal sweat response.2 24 We suggest that the presence of acetylcholine alone will not provide an adequate stimulus for the sweat response in the event of nerve degeneration, as the full response requires the combined action of both transmitters, provided that the receptors remain intact after nerve degeneration.
There is no evidence to suggest that sweat glands and their receptors remain unchanged after nerve degeneration. In fact, the sweating response to acetylcholine is reported to diminish gradually (one to two years) after denervation.22 It is, therefore, possible that in the presence of an autonomic neuropathy of long duration the number of working sweat glands decreases and their distribution becomes irregular. In the original sweat spot test7 the foot was chosen because, impairment being more likely to occur in longer nerve fibres, the lower extremities would be the first to be involved in diabetic autonomic neuropathy. Although this theory has not been tested in other forms of autonomic neuropathy, we have assumed that the same holds true in cases where constipation was associated to a degree of autonomic neuropathy.
The sensitivity of the sweat spot test derived from the receiver operating characteristic curve is rather low at 83%. The most likely explanation is that these constipated patients are a heterogeneous group including patients without autonomic nervous system dysfunction, whose loss of peristaltic activity might instead be the result of intrinsic nerve damage or other motility disorder. A score of 12 on the sweat spot test response appears to be the delimiting number between normal and abnormal subjects in this population. The curve for abnormal subareas has a limited sensitivity, but the specificity is high at 1, for a scoring of 3% of abnormal subareas, which is the demarcation set by Ryder' as a departure from normality.
This study suggests some degree of idiopathic autonomic denervation in patients with slow transit constipation. As with Ryder' was over 70. In the present study, controls were matched for age with the patient group, and as with Ryder's normal subjects,7 no relationship was shown between age and sweat spot test score in the control group. The decrease in spot density with age observed in patients with constipation is not therefore an age related factor, but is most probably related to the duration of the symptoms as most had been constipated for many years.
The loss of sudomotor function seen in constipated patients in this study would at first indicate a degree of impairment of the sympathetic nervous system which would result in the loss of inhibitory tone on gut smooth muscle. This would consequently lead to increased motility because parasympathetic activity would be unopposed by diminished sympathetic activity. Increased motility does not necessarily result in increased propulsion, however. Constipating drugs such as opioids increase motility while inhibiting propulsive activity,'8 and abnormal hypermotility patterns have been reported to occur in the irritable bowel syndrome27 and constipation. '9 We can speculate that increased excitability of the smooth muscle in the bowel because of failure of the inhibitory sympathetic modulation of parasympathetic activity could result in increased mixing and segmental activity of the colon with impaired coordination of peristaltic activity.
If an autonomic neuropathy is present, it is unlikely that a selective sympathetic impairment would occur in the presence of normal parasympathetic function. 28 The decreased sweating function and slow transit constipation seen in our patients could be a consequence of a mild cholinergic dysautonomia, rather than a sign of a more prominent sympathetic failure. Several reports of extreme cases of selective cholinergic dysautonomia identify ileus (or constipation) and loss of sweating as two of the symptoms experienced by those patients.2"3'
The extreme complexity ofthe enteric nervous system with its non-adrenergic non-cholinergic neurones and its connections with the autonomic nervous system and higher neural centres precludes a simple explanation for the effects of autonomic neuropathy in constipation.
In conclusion, idiopathic constipation may well be an early manifestation of an otherwise asymptomatic systemic neuropathy. The 
